Multitargeting strategy using lenvatinib and golvatinib: Maximizing anti-angiogenesis activity in a preclinical cancer model

por Nakazawa, Youya, Kawano, Satoshi, Matsui, Junji, Funahashi, Yasuhiro, Tohyama, Osamu, Muto, Hiroki, Nakagawa, Takayuki, Matsushima, Tomohiro
Publicado 2015

Chemoradiotherapy with FOLFOX for esophageal squamous cell cancer with synchronous rectal cancer: Four case reports and a literature review

por Yoshii, Takako, Hara, Hiroki, Asayama, Masako, Kumekawa, Yosuke, Miyazawa, Shoichi, Takahashi, Naoki, Matsushima, Tomohiro, Shimizu, Satoshi, Saito, Yoshihiro
Publicado 2020

Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway-induced resistance to vascular endothelial growth factor receptor inhibitor

por Nakagawa, Takayuki, Matsushima, Tomohiro, Kawano, Satoshi, Nakazawa, Youya, Kato, Yu, Adachi, Yusuke, Abe, Takanori, Semba, Taro, Yokoi, Akira, Matsui, Junji, Tsuruoka, Akihiko, Funahashi, Yasuhiro
Publicado 2014

Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

por Nakayama, Izuma, Shinozaki, Eiji, Matsushima, Tomohiro, Wakatsuki, Takeru, Ogura, Mariko, Ichimura, Takashi, Ozaka, Masato, Takahari, Daisuke, Suenaga, Mitsukuni, Chin, Keisho, Mizunuma, Nobuyuki, Yamaguchi, Kensei
Publicado 2017

Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel

por Fukuda, Naoki, Takahari, Daisuke, Wakatsuki, Takeru, Osumi, Hiroki, Nakayama, Izuma, Matsushima, Tomohiro, Ichimura, Takashi, Ogura, Mariko, Ozaka, Masato, Suenaga, Mitsukuni, Shinozaki, Eiji, Chin, Keisho, Yamaguchi, Kensei
Publicado 2018

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer

por Wakatsuki, Takeru, Yamamoto, Noriko, Sano, Takeshi, Chin, Keisho, Kawachi, Hiroshi, Takahari, Daisuke, Ogura, Mariko, Ichimura, Takashi, Nakayama, Izuma, Osumi, Hiroki, Matsushima, Tomohiro, Suenaga, Mitsukuni, Shinozaki, Eiji, Hiki, Naoki, Ishikawa, Yuichi, Yamaguchi, Kensei
Publicado 2018

Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer

por Osumi, Hiroki, Shinozaki, Eiji, Suenaga, Mitsukuni, Wakatsuki, Takeru, Nakayama, Izuma, Matsushima, Tomohiro, Ogura, Mariko, Ichimura, Takashi, Takahari, Daisuke, Chin, Keisho, Nagasaki, Toshiya, Konishi, Tsuyoshi, Akiyoshi, Takashi, Fujimoto, Yoshiya, Nagayama, Satoshi, Fukunaga, Yosuke, Ueno, Masashi, Yamaguchi, Kensei
Publicado 2017

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage

por Yamamoto, Yuji, Matsui, Junji, Matsushima, Tomohiro, Obaishi, Hiroshi, Miyazaki, Kazuki, Nakamura, Katsuji, Tohyama, Osamu, Semba, Taro, Yamaguchi, Atsumi, Hoshi, Sachi Suzuki, Mimura, Fusayo, Haneda, Toru, Fukuda, Yoshio, Kamata, Jun-ichi, Takahashi, Keiko, Matsukura, Masayuki, Wakabayashi, Toshiaki, Asada, Makoto, Nomoto, Ken-ichi, Watanabe, Tatsuo, Dezso, Zoltan, Yoshimatsu, Kentaro, Funahashi, Yasuhiro, Tsuruoka, Akihiko
Publicado 2014